GlassScriptPhysician profile
Heidi B Cook
NPI 1285641068
$2,081.17
in general payments reported to CMS, 2019-2025
24 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $414 · 2022: $177 · 2023: $393 · 2024: $708 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,490.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $280.90 | 2024-2025 | Adbry |
| Intuitive Surgical, INC. | $279.61 | 2021 | |
| Abbvie INC. | $253.60 | 2023-2024 | |
| Incyte Corporation | $167.77 | 2022-2025 | Opzelura |
| Amgen INC. | $129.90 | 2023-2025 | Otezla, Otezla |
| Almirall LLC | $111.13 | 2022-2023 | Seysara, Klisyri |
| Dermavant Sciences, INC. | $93.60 | 2023-2024 | Vtama |
| Lilly USA, LLC | $90.00 | 2021-2025 | Taltz, Ebglyss |
| Novartis Pharmaceuticals Corporation | $85.11 | 2022-2025 | |
| Genzyme Corporation | $80.69 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $69.98 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $55.62 | 2024 | Sotyktu |
| Ucb, INC. | $45.42 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $43.95 | 2022-2023 | Dupixent |
| Mayne Pharma Commercial LLC | $39.21 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $39.20 | 2024 | Zoryve |
| Journey Medical Corporation | $36.98 | 2024 | |
| Janssen Biotech, INC. | $36.87 | 2022-2025 | Simponi Aria, Tremfya, Stelara |
| Strata Skin Sciences, INC. | $35.77 | 2025 | Xtrac |
| Biofrontera INC. | $29.72 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
| Pfizer INC. | $25.59 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.63 | 2024 | Cabtreo, Arazlo, Jublia |
| Galderma Laboratories, L.P. | $17.08 | 2024 | |
| Nabriva Therapeutics, Plc | $15.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.